Shulman Joseph's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Feb 11, 2025
- Accession no.
- 0001104659-25-011679
- Filed
- Feb 11, 2025
- Trade date
- Feb 9-11, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $45.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shulman JosephCIK 0001909855 | Officer (Chief Technical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2025 | Common Stock | MOption exerciseAcquired | +2,656 | – | – | 5,313 | Direct | |
| Feb 11, 2025 | Common Stock | MOption exerciseAcquired | +1,562 | – | – | 6,875 | Direct | |
| Feb 11, 2025 | Common Stock | SSaleDisposed | −791 | $57.51 | −$45,490.41 | 6,084 | Direct | |
| Feb 11, 2025 | Common Stock | SSaleDisposed | −3 | $57.54 | −$172.62 | 6.08 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2025 | Common Stock | MOption exerciseDisposed | −2,656 | $0.00 | $0 | 2,656 | Direct | |
| Feb 11, 2025 | Common Stock | MOption exerciseDisposed | −1,562 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.